Alector (ALEC) Cash from Operations Growth (3y) (2021 - 2026)
Alector (ALEC) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 34.32% |
| 10 | Alector | 166.99 Mn | -39.52 Mn | - | -0.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.86% |
| Dec 31, 2025 | 5.19% |
| Sep 30, 2025 | 12.81% |
| Jun 30, 2025 | 5.13% |
| Mar 31, 2025 | -34.81% |
| Dec 31, 2024 | -3.76% |
| Sep 30, 2024 | -28.34% |
| Jun 30, 2024 | -12.13% |
| Mar 31, 2024 | -5.20% |
| Dec 31, 2023 | 1.12% |
| Sep 30, 2023 | -4.47% |
| Jun 30, 2023 | 2.18% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | -19.28% |
| Sep 30, 2022 | -19.34% |
| Jun 30, 2022 | -47.08% |
| Mar 31, 2022 | 97.75% |
| Dec 31, 2021 | -40.79% |
| Sep 30, 2021 | 179.80% |
| Jun 30, 2021 | -37.73% |